Exact Mass: 410.9782056

Exact Mass Matches: 410.9782056

Found 35 metabolites which its exact mass value is equals to given mass value 410.9782056, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Turgorin

C13H15O13S- (411.02333600000003)

Iomazenil

ethyl 11-iodo-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0²,⁶]tetradeca-1(14),3,5,10,12-pentaene-5-carboxylate

C15H14IN3O3 (411.00798840000004)

Discorhabdin Q

(-)-16,17-Dehydrodiscorhabdin B

C18H10BrN3O2S (410.967706)

Oprea1_443725

C16H14ClN3O4S2 (411.0114234)

Pyridinium-3,5-bisthiocarboxylate mononucleotide; P2TMN; Pyridin-1-ium-3,5-bisthiocarboxylate mononucleotide

C12H14NO9PS2 (410.9847604)

Methyl 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate

C16H12BrClFN3O2 (410.9785394)

disodium 5-[(4-nitro-2-sulphonatophenyl)azo]salicylate

C13H7N3Na2O8S (410.9749262)

2-Amino-6-(2-(sulfooxy)ethylsulfonyl)naphthalene-1-sulfonic acid

C12H13NO9S3 (410.97524480000004)

PD 166793

C17H18BrNO4S (411.01398480000006)

sodium 5-hydroxy-6-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-1-sulphonate

C16H10N3NaO7S (411.01371500000005)

r-(+)-2,2-dibromo-1,1-binaphthyl

C20H13Br2 (410.9383918)

6-Bromo-1-carbethoxy-4-methyl-2, 7-dibenz[f,ij]isoquinoline-2,7-dione

C20H14BrNO4 (411.01061440000007)

1,5,9-triazacyclotridecane,trihydrobromide

C9H24Br3N3 (410.9520204)

ethylenediaminetetraacetic acid disodium cobalt salt, hydrate

C10H14CoN2Na2O9 (410.9826654)

H-His-Pro-NH2 · 2 HBr

C11H19Br2N5O2 (410.9905394)

A-TOSYL-(4-IODOMETHYLBENZYL)ISOCYANIDE

C16H14INO2S (410.9789974)

A-TOSYL-(3-IODOMETHYLBENZYL)ISOCYANIDE

C16H14INO2S (410.9789974)

Iomazenil (123I)

C15H14IN3O3 (411.00798840000004)

C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate

[(E)-[3-bromo-4-[(2-fluorophenyl)methoxy]-5-methoxyphenyl]methylideneamino]thiourea

C16H15BrFN3O2S (411.0052322)

(1R,3R)-N-[1-(4-bromophenyl)ethyl]-2,2-dichloro-3-methyl-1-[(S)-methylsulfinyl]cyclopropane-1-carboxamide

C14H16BrCl2NO2S (410.9462116)

2-(3-bromophenyl)-N-(4,5-dihydro-1,3-thiazol-2-yl)quinoline-4-carboxamide

C19H14BrN3OS (411.00408940000005)

2-[[4-(4-Bromophenyl)phenyl]sulfonylamino]-3-methylbutanoic acid

C17H18BrNO4S (411.01398480000006)

4-chloro-3-[(4-chlorophenyl)sulfamoyl]-N-(1H-1,2,4-triazol-5-yl)benzamide

C15H11Cl2N5O3S (410.9959636000001)

(4-Chlorophenyl)-[6,7-dichloro-4-[(dimethylamino)methyl]-5-hydroxy-2-methyl-3-benzofuranyl]methanone

C19H16Cl3NO3 (411.01957160000006)

2,5-dichloro-N-methyl-N-[[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]benzenesulfonamide

C17H15Cl2N3O3S (411.021114)

2-(4-Bromophenyl)-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester

C20H14BrNO4 (411.01061440000007)

N-[5-[(2,6-dichlorophenyl)methylthio]-1,3,4-thiadiazol-2-yl]-5-methyl-2-pyrazinecarboxamide

C15H11Cl2N5OS2 (410.9782056)

Butoconazole(1+)

C19H18Cl3N2S+ (411.0256218)

BX430

C15H15Br2N3O (410.958178)

BX430 is a potent and selective noncompetitive allosteric human P2X4 receptor channels antagonist with an IC50 of 0.54 μM. BX430 has species specificity. BX430 is used for chronic pain and cardiovascular disease.

(3s,10s)-5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(21),2(12),4,7,14,16,18-heptaene-6,13-dione

C18H10BrN3O2S (410.967706)

2-(3,5-dibromo-4-butoxy-1-hydroxy-4-methoxycyclohexa-2,5-dien-1-yl)ethanimidic acid

C13H19Br2NO4 (410.96807340000004)

2-(4-{1,6-dichloro-3h-pyrrolo[2,3-c]quinolin-4-yl}-1,3-thiazol-2-yl)phenol

C20H11Cl2N3OS (410.99998560000006)